FDA OKs Clinical Trial to Test Bacteriophage-Based Treatment for Crohn’s
News
The U.S. Food and Drug Administration (FDA) recently cleared a Phase 1/2a clinical trial to study a set of bacteriophages designed to treat inflammatory bowel diseases (IBDs), specifically Crohn’s disease. ... Read more